RC
CELG

Roundview Capital’s Celgene Corp CELG Stock Holding History

Roundview Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,821
Closed -$479K – 229
2019
Q3 		$479K Sell
4,821
-150
-3% -$14.3K 0.1% 175
2019
Q2 		$460K Hold
4,971
– – 0.1% 176
2019
Q1 		$469K Sell
4,971
-1,805
-27% -$158K 0.11% 163
2018
Q4 		$434K Buy
6,776
+261
+4% +$19.3K 0.12% 151
2018
Q3 		$583K Sell
6,515
-405
-6% -$35.8K 0.14% 157
2018
Q2 		$550K Sell
6,920
-85
-1% -$7.06K 0.14% 159
2018
Q1 		$625K Sell
7,005
-12,523
-64% -$1.2M 0.18% 144
2017
Q4 		$2.04M Sell
19,528
-5,120
-21% -$578K 0.53% 61
2017
Q3 		$3.59M Buy
24,648
+2,150
+10% +$293K 1.03% 22
2017
Q2 		$2.92M Buy
22,498
+520
+2% +$63.7K 0.85% 28
2017
Q1 		$2.73M Buy
21,978
+660
+3% +$79K 0.85% 26
2016
Q4 		$2.47M Buy
21,318
+100
+0.5% +$11.1K 0.79% 34
2016
Q3 		$2.22M Buy
21,218
+150
+0.7% +$16.2K 0.78% 39
2016
Q2 		$2.08M Buy
21,068
+2,600
+14% +$269K 0.76% 41
2016
Q1 		$1.85M Sell
18,468
-1,300
-7% -$134K 0.69% 44
2015
Q4 		$2.37M Buy
19,768
+365
+2% +$42.2K 0.94% 26
2015
Q3 		$2.1M Sell
19,403
-280
-1% -$34.7K 0.9% 29
2015
Q2 		$2.28M Hold
19,683
– – 0.86% 31
2015
Q1 		$2.27M Buy
19,683
+1,935
+11% +$231K 0.9% 29
2014
Q4 		$1.99M Buy
17,748
+14,300
+415% +$1.51M 0.81% 32
2014
Q3 		$327K Buy
3,448
+320
+10% +$28.9K 0.15% 104
2014
Q2 		$269K Buy
+3,128
New +$238K 0.11% 132
2014
Q1 		– Sell
-3,190
Closed -$270K – 147
2013
Q4 		$270K Hold
3,190
– – 0.12% 117
2013
Q3 		$246K Buy
+3,190
New +$224K 0.13% 110

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Roundview Capital's CELG Position: Q4 2019 in Review

Roundview Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,821 shares — an estimated $479K sold.

Roundview Capital first reported a position in CELG in Q3 2013 and held it in 24 quarters. The position peaked at $3.59M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Roundview Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Roundview Capital sold 4,821 Celgene Corp shares in Q4 2019, an estimated $479K.
  • Roundview Capital first reported a position in Celgene Corp in Q3 2013 and held it in 24 quarters.
  • Roundview Capital's Celgene Corp position peaked at $3.59M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Roundview Capital's 13F filing for Q4 2019, filed 10 Feb 2020.